Vectura GmbH,(formerly Activaero GmbH)
Vectura GmbH
Vectura, a FTSE250 company listed on the London Stock Exchange (LSE: VEC), is an industry-leading inhaled airways disease focused business with proprietary formulation and devices across DPI, pMDI and smart nebulisation platforms. With our extensive range of technologies, capabilities and collaborations, we believe we can become a leader in the development of inhalation products, increasing our ability to help patients suffering from respiratory diseases.
Vectura has seven inhaled, four non-inhaled and ten oral products marketed by partners with growing global royalty streams, and a portfolio of drugs in clinical development, a number of which have licence agreements with several global pharmaceutical and biotechnology companies.
For further information, please visit Vectura's website at www.vectura.com
Robert-Koch-Allee 29
Deutschland-82131 Gauting
Telefon: +49 (0) 89 897969-0
Fax: +49 (0) 89 897969-22
http://www.vectura.com
info@
vectura.com